筋肉痛治療の世界市場レポート 2025年

筋肉痛治療市場は、筋骨格系障害の有病率の増加により成長が見込まれています。筋骨格系障害は筋肉、骨、関節に影響を及ぼし、痛み、こわばり、運動制限を引き起こします。症例増加の要因としては、人口の高齢化、座りがちなライフスタイル、慢性疾患の増加などが挙げられます。治療は、痛みの軽減、可動性の改善、合併症の予防、全体的な生活の質と機能の向上により、症状を緩和することを目的としています。Lancet誌による2023年11月の研究によると、2020年には世界で推定4億9,400万人が筋骨格系障害を経験し、2050年には115％増加すると予測されています。その結果、筋肉痛治療市場は拡大しています。

この市場の主要企業は、有効性と利便性を向上させるために局所鎮痛剤などの製品を開発し、技術革新を進めています。これらの医薬品は、皮膚に直接塗布して標的部位の痛みを和らげるもので、筋肉痛、関節炎、軽度の怪我などによく使用されます。例えば、2024年7月、Wellness Formulations LLCは、高度な浸透促進剤と皮膚コンディショナーとともに鎮痛のためのメントールを特徴とするRalli Rapid Pain Reliefを発表しました。ジェル、スプレー、ロールオンタイプがあり、筋肉痛、関節痛、関節炎、ひずみ、捻挫を素早く長時間緩和します。そのため、患部に直接塗ることができ、揉んだりマッサージしたりする必要がないです。

2022年2月、米国を拠点に理学療法と整形外科リハビリテーション・サービスを提供するアスレティコ・フィジカル・セラピーは、ピボット・ヘルス・ソリューションズの買収を非公開の金額で完了しました。この戦略的な動きは、地理的な範囲を拡大し、理学療法と作業衛生の能力を強化することで、筋肉痛治療市場におけるアスレティコの地位を強化します。この買収はまた、アスレティコに経験豊富なリーダーシップをもたらし、高水準の患者ケアを提供するというコミットメントを強化するものです。米国を拠点とするピボット・ヘルス・ソリューションズ社は、理学療法、産業保健、オンサイト・コーポレート・ヘルス・サービスを専門とし、筋肉痛やその他の身体疾患の治療に注力しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界筋肉痛治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の筋肉痛治療市場：成長率分析
• 世界の筋肉痛治療市場の実績：規模と成長, 2019-2024
• 世界の筋肉痛治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界筋肉痛治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の筋肉痛治療市場薬物治療による、実績と予測, 2019-2024, 2024-2029F, 2034F
• 鎮痛剤
• 筋弛緩剤
• 局所鎮痛剤
• その他の薬物療法
• 世界の筋肉痛治療市場非薬物治療による、実績と予測, 2019-2024, 2024-2029F, 2034F
• 理学療法
• マッサージセラピー
• 鍼
• 温熱療法と冷却療法
• 運動とストレッチ
• その他の非薬物療法
• 世界の筋肉痛治療市場痛みの種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 急性筋肉痛
• 慢性的な筋肉痛
• 世界の筋肉痛治療市場筋肉痛の原因別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 過度の使用と負担
• 怪我や外傷
• 炎症性疾患
• 神経疾患
• 感染症
• 筋肉痛のその他の原因
• 世界の筋肉痛治療市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• その他の用途
• 世界の筋肉痛治療市場鎮痛剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非ステロイド性抗炎症薬（NSAID）
• アセトアミノフェン
• 世界の筋肉痛治療市場筋弛緩薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 中枢性筋弛緩薬
• 末梢作用型筋弛緩薬
• 世界の筋肉痛治療市場局所鎮痛剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• クリームと軟膏
• ジェル＆スプレー
• パッチ
• 世界の筋肉痛治療市場その他の薬物療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• コルチコステロイド
• 抗うつ薬
• 抗けいれん薬

第7章 地域別・国別分析

• 世界の筋肉痛治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の筋肉痛治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 筋肉痛治療市場：競合情勢
• 筋肉痛治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bayer AG
• Sanofi SA
• Bristol Myers Squibb Company
• AstraZeneca PLC
• Novartis International AG
• GlaxoSmithKline plc（GSK）
• Eli Lilly and Company
• Amgen Inc.
• Teva Pharmaceutical Industries Ltd.
• Baxter International Inc.
• Haleon Plc
• Select Medical Holdings Corporation
• Purdue Pharma
• Endo Pharmaceuticals Inc.
• Concentra Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 筋肉痛治療市場2029：新たな機会を提供する国
• 筋肉痛治療市場2029：新たな機会を提供するセグメント
• 筋肉痛治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Treatment for muscle pain involves managing and easing discomfort and inflammation in muscles. This typically includes rest, applying heat or cold therapy, using over-the-counter pain relievers, and sometimes undergoing physical therapy or taking prescription medications for more severe cases. The goal of effective treatment is to reduce pain, facilitate healing, and restore normal muscle function.

Pharmacological approaches to treating muscle pain include analgesics, muscle relaxants, topical analgesics, and other medications. Analgesics are drugs specifically designed to alleviate pain without causing unconsciousness. Non-pharmacological treatments encompass physical therapy, massage therapy, acupuncture, heat and cold therapy, exercise, stretching, and other methods. These treatments target various types of pain, such as acute and chronic muscle pain resulting from overuse, injury, inflammation, neurological conditions, infections, and other causes. They are administered in various settings, including hospitals and clinics.

The muscle pain treatment market research report is one of a series of new reports from The Business Research Company that provides muscle pain treatment market statistics, including muscle pain treatment industry global market size, regional shares, competitors with a muscle pain treatment market share, detailed muscle pain treatment market segments, market trends and opportunities, and any further data you may need to thrive in the muscle pain treatment industry. This muscle pain treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The muscle pain treatment market size has grown strongly in recent years. It will grow from $12.95 billion in 2024 to $13.67 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to aging population with a higher incidence of chronic pain conditions, an increase in sports injuries due to higher participation rates, the prevalence of manual labor jobs leading to musculoskeletal disorders, sedentary lifestyles contributing to muscle stiffness and pain, and a lack of exercise causing muscle atrophy and pain.

The muscle pain treatment market size is expected to see strong growth in the next few years. It will grow to $16.79 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to increasing adoption of non-opioid and non-invasive pain management treatments, rising healthcare expenditures and demand for effective pain management solutions, regulatory approvals for new pain management therapies and devices, emphasis on preventive healthcare to mitigate chronic pain conditions, and growing demand for alternative therapies like acupuncture and chiropractic care. Major trends in the forecast period include telehealth and virtual consultations for pain management, the development of wearable pain relief devices and smart clothing, biopharmaceutical innovations in pain treatment, AI-driven personalized pain management solutions, and regenerative medicine techniques for tissue repair and pain reduction.

The muscle pain treatment market is expected to grow due to the increasing prevalence of musculoskeletal disorders. Musculoskeletal disorders affect the muscles, bones, and joints, causing pain, stiffness, and limited movement. Factors contributing to rising cases include aging populations, sedentary lifestyles, and the increasing incidence of chronic conditions. Treatment aims to alleviate symptoms by reducing pain, improving mobility, preventing complications, and enhancing overall quality of life and function. According to a November 2023 study by The Lancet, an estimated 494 million people globally experienced musculoskeletal disorders in 2020, with projections suggesting a potential 115% increase by 2050. As a result, the muscle pain treatment market is expanding.

Leading companies in this market are innovating by developing products such as topical analgesics to improve effectiveness and user convenience. These medications are applied directly to the skin to relieve pain in targeted areas, commonly used for muscle aches, arthritis, and minor injuries. For example, in July 2024, Wellness Formulations LLC introduced Ralli Rapid Pain Relief, featuring menthol for pain relief along with advanced penetration enhancers and skin conditioners. Available in gel, spray, and roll-on formats, it offers quick and long-lasting relief from muscle aches, joint pain, arthritis, strains, and sprains, without leaving a greasy residue. This allows for easy application directly to affected areas, eliminating the need for rubbing or massaging.

In February 2022, Athletico Physical Therapy, a US-based provider of physical therapy and orthopedic rehabilitation services, completed the acquisition of Pivot Health Solutions for an undisclosed sum. This strategic move strengthens Athletico's position in the muscle pain treatment market by expanding its geographic reach and enhancing capabilities in physical therapy and occupational health. The acquisition also brings seasoned leadership to Athletico and reinforces its commitment to delivering high standards of patient care. Pivot Health Solutions, also based in the US, specializes in physical therapy, occupational health, and onsite corporate health services, focusing on treating muscle pain and other physical ailments.

Major companies operating in the muscle pain treatment market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol Myers Squibb Company, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Baxter International Inc., Haleon Plc, Select Medical Holdings Corporation, Purdue Pharma, Endo Pharmaceuticals Inc., Concentra Inc., Athletico Physical Therapy, ATI Physical Therapy Inc., Physiotherapy Associates Inc, NovaCare Rehabilitation Inc, CORA Health Services Inc., Select Physical Therapy Holdings Inc., ProActive Physical Therapy

North America was the largest region in the muscle pain treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the muscle pain treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the muscle pain treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The muscle pain treatment market consists of revenues earned by entities by providing services such as chiropractic care, hydrotherapy, occupational therapy, transcutaneous electrical nerve stimulation (TENS), cognitive-behavioral therapy (CBT), and myofascial release therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The muscle pain treatment market also includes sales of acetaminophen, corticosteroids, and nonsteroidal anti-inflammatory drugs (NSAIDs). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Muscle Pain Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on muscle pain treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for muscle pain treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The muscle pain treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Pharmacological Treatment: Analgesics; Muscle Relaxants; Topical Analgesics; Other Pharmacological Treatments
• 2) By Non-Pharmacological Treatment: Physical Therapy; Massage Therapy; Acupuncture; Heat And Cold Therapy; Exercise And Stretching; Other Non-Pharmacological Treatments
• 3) By Type Of Pain: Acute Muscle Pain; Chronic Muscle Pain
• 4) By Cause Of Muscle Pain: Overuse And Strain; Injury Or Trauma; Inflammatory Conditions; Neurological Conditions; Infections; Other Cause Of Muscle Pain
• 5) By Application: Hospital; Clinic; Other Applications
• Subsegments:
• 1) By Analgesics: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Acetaminophen
• 2) By Muscle Relaxants: Centrally Acting Muscle Relaxants; Peripherally Acting Muscle Relaxants
• 3) By Topical Analgesics: Creams & Ointments; Gels & Sprays; Patches
• 4) By Other Pharmacological Treatments: Corticosteroids; Antidepressants; Anticonvulsants
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Roche Holding AG; Merck & Co. Inc.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Muscle Pain Treatment Market Characteristics

3. Muscle Pain Treatment Market Trends And Strategies

4. Muscle Pain Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Muscle Pain Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Muscle Pain Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Muscle Pain Treatment Market Growth Rate Analysis
• 5.4. Global Muscle Pain Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Muscle Pain Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Muscle Pain Treatment Total Addressable Market (TAM)

6. Muscle Pain Treatment Market Segmentation

• 6.1. Global Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Analgesics
• Muscle Relaxants
• Topical Analgesics
• Other Pharmacological Treatments
• 6.2. Global Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Physical Therapy
• Massage Therapy
• Acupuncture
• Heat And Cold Therapy
• Exercise And Stretching
• Other Non-Pharmacological Treatments
• 6.3. Global Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Muscle Pain
• Chronic Muscle Pain
• 6.4. Global Muscle Pain Treatment Market, Segmentation By Cause Of Muscle Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Overuse And Strain
• Injury Or Trauma
• Inflammatory Conditions
• Neurological Conditions
• Infections
• Other Cause Of Muscle Pain
• 6.5. Global Muscle Pain Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Clinic
• Other Applications
• 6.6. Global Muscle Pain Treatment Market, Sub-Segmentation Of Analgesics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
• Acetaminophen
• 6.7. Global Muscle Pain Treatment Market, Sub-Segmentation Of Muscle Relaxants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Centrally Acting Muscle Relaxants
• Peripherally Acting Muscle Relaxants
• 6.8. Global Muscle Pain Treatment Market, Sub-Segmentation Of Topical Analgesics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Creams & Ointments
• Gels & Sprays
• Patches
• 6.9. Global Muscle Pain Treatment Market, Sub-Segmentation Of Other Pharmacological Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroids
• Antidepressants
• Anticonvulsants

7. Muscle Pain Treatment Market Regional And Country Analysis

• 7.1. Global Muscle Pain Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Muscle Pain Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Muscle Pain Treatment Market

• 8.1. Asia-Pacific Muscle Pain Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Muscle Pain Treatment Market

• 9.1. China Muscle Pain Treatment Market Overview
• 9.2. China Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Muscle Pain Treatment Market

• 10.1. India Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Muscle Pain Treatment Market

• 11.1. Japan Muscle Pain Treatment Market Overview
• 11.2. Japan Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Muscle Pain Treatment Market

• 12.1. Australia Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Muscle Pain Treatment Market

• 13.1. Indonesia Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Muscle Pain Treatment Market

• 14.1. South Korea Muscle Pain Treatment Market Overview
• 14.2. South Korea Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Muscle Pain Treatment Market

• 15.1. Western Europe Muscle Pain Treatment Market Overview
• 15.2. Western Europe Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Muscle Pain Treatment Market

• 16.1. UK Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Muscle Pain Treatment Market

• 17.1. Germany Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Muscle Pain Treatment Market

• 18.1. France Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Muscle Pain Treatment Market

• 19.1. Italy Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Muscle Pain Treatment Market

• 20.1. Spain Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Muscle Pain Treatment Market

• 21.1. Eastern Europe Muscle Pain Treatment Market Overview
• 21.2. Eastern Europe Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Muscle Pain Treatment Market

• 22.1. Russia Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Muscle Pain Treatment Market

• 23.1. North America Muscle Pain Treatment Market Overview
• 23.2. North America Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Muscle Pain Treatment Market

• 24.1. USA Muscle Pain Treatment Market Overview
• 24.2. USA Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Muscle Pain Treatment Market

• 25.1. Canada Muscle Pain Treatment Market Overview
• 25.2. Canada Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Muscle Pain Treatment Market

• 26.1. South America Muscle Pain Treatment Market Overview
• 26.2. South America Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Muscle Pain Treatment Market

• 27.1. Brazil Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Muscle Pain Treatment Market

• 28.1. Middle East Muscle Pain Treatment Market Overview
• 28.2. Middle East Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Muscle Pain Treatment Market

• 29.1. Africa Muscle Pain Treatment Market Overview
• 29.2. Africa Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Muscle Pain Treatment Market Competitive Landscape And Company Profiles

• 30.1. Muscle Pain Treatment Market Competitive Landscape
• 30.2. Muscle Pain Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Muscle Pain Treatment Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Sanofi SA
• 31.3. Bristol Myers Squibb Company
• 31.4. AstraZeneca PLC
• 31.5. Novartis International AG
• 31.6. GlaxoSmithKline plc (GSK)
• 31.7. Eli Lilly and Company
• 31.8. Amgen Inc.
• 31.9. Teva Pharmaceutical Industries Ltd.
• 31.10. Baxter International Inc.
• 31.11. Haleon Plc
• 31.12. Select Medical Holdings Corporation
• 31.13. Purdue Pharma
• 31.14. Endo Pharmaceuticals Inc.
• 31.15. Concentra Inc.

32. Global Muscle Pain Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Muscle Pain Treatment Market

34. Recent Developments In The Muscle Pain Treatment Market

35. Muscle Pain Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Muscle Pain Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Muscle Pain Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Muscle Pain Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer